Global Patent Index - EP 1019502 A2

EP 1019502 A2 2000-07-19 - HUMAN ORPHAN RECEPTOR NTR-1

Title (en)

HUMAN ORPHAN RECEPTOR NTR-1

Title (de)

HUMANE WAISENREZEPTOR NTR-1

Title (fr)

NOUVEAU RECEPTEUR ORPHELIN

Publication

EP 1019502 A2 (EN)

Application

EP 98939199 A

Priority

  • US 9816202 W
  • US 5486997 P

Abstract (en)

[origin: WO9907738A2] The present invention provides for a nucleic acid sequence, designated as HUMAN NTR-1, that encodes a novel orphan receptor expressed in pancreas and fetal heart. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the HUMAN NTR-1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between NTR-1 and agents that initiate signal transduction through binding to NTR-1.

IPC 1-7 (main, further and additional classification)

C12N 15/12; A61K 38/16; C07K 14/705; C07K 16/28; C12N 15/62; C12N 15/63; C12P 21/08

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); C07K 14/47 (2006.01); C07K 14/705 (2006.01); C07K 16/18 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01)

CPC (invention and additional information)

C07K 14/70578 (2013.01); C07K 2319/00 (2013.01)

Citation (search report)

See references of WO 9907738A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9907738 A2 19990218; WO 9907738 A3 19990415; AU 8767698 A 19990301; CA 2299619 A1 19990218; EP 1019502 A2 20000719; JP 2001512667 A 20010828

INPADOC legal status


2004-09-08 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20040302

2000-07-19 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000204

2000-07-19 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE